All stock lists
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
21.07+0.69 (+3.38%)
Insider Score
––Not scored
AMRX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AMRX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 796.20 M | 722.52 M | 814.32 M | 784.51 M | 724.51 M | 695.42 M |
| Revenue Growth (YoY) | 9.89 % | 3.90 % | 11.47 % | 11.68 % | 3.24 % | 5.50 % |
| Cost of Revenue | 461.69 M | 402.41 M | 517.13 M | 510.54 M | 438.25 M | 439.53 M |
| Gross Profit | 334.51 M | 320.11 M | 297.19 M | 273.97 M | 286.25 M | 255.89 M |
| SG&A Expense | 148.72 M | 138.86 M | 146.46 M | 137.81 M | 124.27 M | 118.29 M |
| R&D Expense | 41.10 M | 38.38 M | 34.82 M | 63.35 M | 49.98 M | 41.81 M |
| Operating Expenses | 188.53 M | 177.24 M | 182.69 M | 274.09 M | 174.88 M | 155.54 M |
| Operating Income | 145.98 M | 142.87 M | 114.50 M | -117.00 K | 111.37 M | 100.35 M |
| Pretax Income | 70.99 M | 80.18 M | 55.23 M | -5.22 M | 51.71 M | 37.49 M |
| Tax Provision | 1.38 M | 2.18 M | 5.66 M | -23.36 M | 16.10 M | 12.87 M |
| Net Income | 57.66 M | 62.26 M | 35.08 M | 2.37 M | 22.42 M | 12.20 M |
| EPS (Basic) | 0.18 | 0.20 | 0.11 | 0.01 | 0.07 | 0.04 |
| EPS (Diluted) | 0.18 | 0.19 | 0.11 | 0.01 | 0.07 | 0.04 |
| Shares Outstanding | 319.20 M | 316.02 M | 313.37 M | 314.17 M | 313.74 M | 311.05 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.